Literature DB >> 29501360

Depression and Coping Behaviors Are Key Factors in Understanding Pain in Interstitial Cystitis/Bladder Pain Syndrome.

Abi Muere1, Dean A Tripp2, J Curtis Nickel3, Kerri-Lynn Kelly3, Robert Mayer4, Michel Pontari5, Robert Moldwin6, Lesley K Carr7, Claire C Yang8, Jorgen Nordling9.   

Abstract

BACKGROUND: Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a urologic chronic pelvic pain syndrome with suboptimal treatment outcomes. Catastrophizing is an empirically supported risk factor for greater IC/BPS pain. AIMS: In this study, a moderated multiple mediation model is tested in which several additional psychosocial risk factors (depression, illness and wellness-focused behavioral coping strategies) are proposed as mediators or moderators in the existing relationship between catastrophizing and IC/BPS pain.
DESIGN: The present questionnaire study employed a cross-sectional design. SETTINGS AND PARTICIPANTS: Female patients with an IC/BPS diagnosis (n = 341) were recruited at tertiary care sites.
METHODS: Participants completed questionnaires assessing pain, catastrophizing, behavioral coping strategies, and depressive symptoms. Aggregate factor scores were calculated following exploratory factor analyses.
RESULTS: It was found that patients with a greater tendency to catastrophize were more likely to engage in illness-focused coping strategies, which contributed to the reporting of greater sensory and affective pain. Furthermore, this mediating effect of illness-focused coping on affective pain was more likely to occur in those patients reporting greater depressive symptoms.
CONCLUSIONS: Illness-focused behavioral coping is an important mechanism between maladaptive pain cognition and aspects of patient pain, with patients reporting greater depressive symptoms at increased risk for elevated pain. Patient management techniques, including screening for catastrophizing, coping, and depression, are recommended to enrich IC/BPS management.
Copyright © 2017 American Society for Pain Management Nursing. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29501360     DOI: 10.1016/j.pmn.2017.11.001

Source DB:  PubMed          Journal:  Pain Manag Nurs        ISSN: 1524-9042            Impact factor:   1.929


  6 in total

1.  Depression and helplessness impact interstitial cystitis/bladder pain syndrome pain over time.

Authors:  Alison Crawford; Dean A Tripp; J Curtis Nickel; Lesley Carr; Robert Moldwin; Laura Katz; Abi Muere
Journal:  Can Urol Assoc J       Date:  2019-10       Impact factor: 1.862

2.  Cognition, Emotion, and the Bladder: Psychosocial Factors in bladder pain syndrome and interstitial cystitis (BPS/IC).

Authors:  Sula Windgassen; Lindsey McKernan
Journal:  Curr Bladder Dysfunct Rep       Date:  2020-01-31

Review 3.  Comorbidities of bladder pain syndrome in the context of the HITOP distress category: a systematic review and meta-analysis.

Authors:  Linda Fischer-Grote; Vera Fössing; Martin Aigner; Markus Boeckle; Elisabeth Fehrmann
Journal:  Int Urogynecol J       Date:  2022-03-09       Impact factor: 1.932

4.  Clinical Approach to Recurrent Voiding Dysfunction, Dysuria, and Pelvic Pain Persisting for at Least 3 Months.

Authors:  Su Jin Kim; Khae Hawn Kim
Journal:  Int Neurourol J       Date:  2022-09-30       Impact factor: 3.038

5.  Cyclophosphamide-induced cystitis results in NLRP3-mediated inflammation in the hippocampus and symptoms of depression in rats.

Authors:  Nathan A Hirshman; Francis M Hughes; Huixia Jin; William T Harrison; Simon W White; Isabelle Doan; Shelby N Harper; Patrick D Leidig; J Todd Purves
Journal:  Am J Physiol Renal Physiol       Date:  2019-12-23

6.  Women's Experiences of Interstitial Cystitis/Painful Bladder Syndrome.

Authors:  Angela Kirkham; Katherine Swainston
Journal:  West J Nurs Res       Date:  2021-01-29       Impact factor: 1.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.